Disruption of the intestinal mucosal barrier, alterations in the microbiota, and microbial translocation lead to systemic inflammation, further impacting the hosts immune and metabolic homeostasis [4]
If you are unsure whether you qualify, completing the online intake form is the fastest way to find out
FDA approval announcement for Wegovy 7.2 mg, March 2026
Together, we can unlock a healthier, happier you
The clinical question that remains: does the added complexity of dual-hormone therapy justify the incremental weight loss over semaglutide alone
To mitigate this drawback, the pharmacological administration of GIP, primarily known for its insulinotropic and mild appetite-suppressing properties [7], is also suggested to have an anti-emetic effect, potentially allowing GIP co-agonism to increase tolerability to the GLP-1 component [8]